FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Biofrontera's Free Cash Flow for the
three
months ended in Dec. 2023 was $-8.87 Mil. Biofrontera's Revenue for the
three
months ended in Dec. 2023 was $10.60 Mil. Therefore, Biofrontera's FCF Margin % for the quarter that ended in Dec. 2023 was -83.67%.
The historical rank and industry rank for Biofrontera's FCF Margin % or its related term are showing as below:
BFRI'
s FCF Margin % Range Over the Past 10 Years
Min: -145.96 Med: -73.08 Max: -56.63
Current: -73.1
During the past 5 years, the highest FCF Margin % of Biofrontera was -56.63%. The lowest was -145.96%. And the median was -73.08%.
BFRI's FCF Margin % is ranked worse than 87.62% of 1026
companies
in the Drug Manufacturers industry
Industry Median: -0.675
vs BFRI: -73.10
Biofrontera FCF Margin % Historical Data
The historical data trend for Biofrontera's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Biofrontera's FCF Margin %
For the Drug Manufacturers - Specialty & Generic subindustry, Biofrontera's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biofrontera's FCF Margin % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Biofrontera's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Biofrontera's FCF Margin % falls into.
Biofrontera FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Biofrontera's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biofrontera FCF Margin % Related Terms
Thank you for viewing the detailed overview of Biofrontera's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BFRI has been successfully added to your 